[1]
“Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models”, ADMET DMPK, vol. 8, no. 4, pp. 375–390, Sep. 2020, doi: 10.5599/admet.881.